The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Mikhail Kosiborod et al.|Nature Medicine|2022Cited by 889
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceMintu P. Turakhia, Hiro Yamasaki, Peter J. Blankestijn et al.|European Heart Journal|2018Cited by 285